SERUM PROLACTIN RESPONSE TO THYROTROPIN-RELEASING-HORMONE AND METOCLOPRAMIDE IN PATIENTS WITH PROLACTIN-SECRETING TUMORS BEFORE AND AFTER TRANSSPHENOIDAL SURGERY
SERUM PROLACTIN RESPONSE TO THYROTROPIN-RELEASING-HORMONE AND METOCLOPRAMIDE IN PATIENTS WITH PROLACTIN-SECRETING TUMORS BEFORE AND AFTER TRANSSPHENOIDAL SURGERY
复制标题
DOI:
10.1210/jcem-47-5-1148
复制
发表时间:
1978-01-01
影响因子:
5.8
通讯作者:
ANILE, C
中科院分区:
文献类型:
--
作者:
BARBARINO, A;DEMARINIS, L;ANILE, C
Seven female patients with amenorrhea, galactorrhea and hyperprolactinemia were examined before and after selective transsphenoidal removal of a PRL[prolactin]-secreting microadenoma. Before adenomectomy, metoclopramide (MCP; 10 mg orally) and TRH [thyrotropin-releasing hormone] (200 .mu.g i.v.) did not increase PRL blood levels in any of the 7 patients. After oral administration of 10 mg MCP a positive response was noted in a group of 8 lactating women 3 days postpartum. After surgery, serum PRL level returned to normal in all patients. A positive PRL response to MCP and TRH was found in 6 of the 7 patients 1 mo. after surgery. One patient who had the lowest PRL level failed to show a PRL increase after both stimuli. Hypothalamic pituitary function apparently can be restored to normal after transsphenoidal removal of PRL-secreting pituitary tumors.